Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 0.00% is 100% below its 5-year average of 66.67%, near the low end of its 5-year range (0.00%–100.00%).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
46.15%
GROSS MARGIN AVG 5Y
66.67%
GROSS MARGIN AVG 10Y
39.02%
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
-100.00%
CURRENT VS 5Y AVG
-100.00%
CURRENT VS 10Y AVG
-100.00%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
47.19%
median of 512 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Market Cap
$31.14M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$30.81M
Gross Margin
83.79%
TTM Avg
85.97%
3Y Avg
84.60%
5Y Avg
84.69%
Market Cap
$32.55M
Gross Margin
41.73%
TTM Avg
31.44%
3Y Avg
27.18%
5Y Avg
29.99%
Market Cap
$29.24M
Gross Margin
-3398.93%
TTM Avg
-1699.46%
3Y Avg
-849.73%
5Y Avg
-566.49%
Market Cap
$33.79M
Gross Margin
57.46%
TTM Avg
78.73%
3Y Avg
89.36%
5Y Avg
76.24%
Market Cap
$33.85M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
10.20%
Market Cap
$28.43M
Gross Margin
-717.37%
TTM Avg
-308.69%
3Y Avg
-108.42%
5Y Avg
-83.18%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BeyondSpring Inc. (BYSI) | $31.35M | 0.00% | 0.00% | 46.15% | 66.67% |
| Context Therapeutics Inc. (CNTX)vs › | $31.14M | 0.00% | 0.00% | 0.00% | 0.00% |
| CervoMed Inc. (CRVO)vs › | $31.11M | 0.00% | 0.00% | 0.00% | 0.00% |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $30.81M | 83.79% | 85.97% | 84.60% | 84.69% |
| EUDA Health Holdings Limited (EUDA)vs › | $32.55M | 41.73% | 31.44% | 27.18% | 29.99% |
| GridAI Technologies Corp. (GRDX)vs › | $29.24M | -3398.93% | -1699.46% | -849.73% | -566.49% |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.79M | 57.46% | 78.73% | 89.36% | 76.24% |
| Grace Therapeutics, Inc. (GRCE)vs › | $33.85M | 0.00% | 0.00% | 0.00% | 10.20% |
| aTyr Pharma, Inc. (ATYR)vs › | $28.43M | -717.37% | -308.69% | -108.42% | -83.18% |
| HeartBeam, Inc. (BEAT)vs › | $34.65M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 100.00% |
| 2024-06-30 | 100.00% |
| 2024-03-31 | 100.00% |
| 2023-12-31 | 100.00% |
| 2023-09-30 | 100.00% |
| 2023-06-30 | 100.00% |
| 2023-03-31 | 100.00% |
| 2022-12-31 | 100.00% |
| 2022-09-30 | 100.00% |
| 2022-06-30 | 100.00% |
| 2022-03-31 | 100.00% |
| 2021-12-31 | 100.00% |
| 2021-09-30 | 100.00% |
| 2021-06-30 | 100.00% |
| 2021-03-31 | 100.00% |
| 2020-12-31 | 100.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
